The Beauty Health Company (SKIN)
NASDAQ: SKIN · IEX Real-Time Price · USD
3.240
+0.180 (5.88%)
At close: Apr 26, 2024, 4:00 PM
3.300
+0.060 (1.85%)
After-hours: Apr 26, 2024, 5:08 PM EDT
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for SKIN stock have an average target of 4.50, with a low estimate of 1.50 and a high estimate of 10. The average target predicts an increase of 38.89% from the current stock price of 3.24.
Analyst Consensus: Hold
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for SKIN stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 7 | 6 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +54.32% | Mar 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +23.46% | Mar 14, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $2 → $3 | Sell | Reiterates | $2 → $3 | -7.41% | Mar 13, 2024 |
| Stifel | Stifel | Hold Reiterates $3 → $4 | Hold | Reiterates | $3 → $4 | +23.46% | Mar 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $2.5 → $4 | Hold | Maintains | $2.5 → $4 | +23.46% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
409.32M
from 397.99M
Increased by 2.85%
Revenue Next Year
452.12M
from 409.32M
Increased by 10.46%
EPS This Year
-0.10
from -0.76
EPS Next Year
0.04
from -0.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 430.1M | 486.6M | 538.7M | 546.3M |
| Avg | 409.3M | 452.1M | 506.4M | 530.7M |
| Low | 390.8M | 424.2M | 458.4M | 509.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 8.1% | 18.9% | 19.1% | 7.9% |
| Avg | 2.8% | 10.5% | 12.0% | 4.8% |
| Low | -1.8% | 3.6% | 1.4% | 0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.03 | 0.25 | 0.33 |
| Avg | -0.10 | 0.04 | 0.25 |
| Low | -0.35 | -0.20 | 0.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 780.3% |
| Avg | - | - | 575.9% |
| Low | - | - | 377.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.